Title : Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.

Pub. Date : 2018 Apr

PMID : 29135083






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors. Valproic Acid histone deacetylase 9 Homo sapiens
2 The HDAC inhibitory activity of valproic acid (VPA) has led to on-going evaluation of it as an anticancer agent. Valproic Acid histone deacetylase 9 Homo sapiens
3 The HDAC inhibitory activity of valproic acid (VPA) has led to on-going evaluation of it as an anticancer agent. Valproic Acid histone deacetylase 9 Homo sapiens
4 The histone deacetylase (HDAC) inhibitor AN446, a prodrug of VPA, releases the acid upon metabolic degradation. Valproic Acid histone deacetylase 9 Homo sapiens
5 The histone deacetylase (HDAC) inhibitor AN446, a prodrug of VPA, releases the acid upon metabolic degradation. Valproic Acid histone deacetylase 9 Homo sapiens